We are live on ! Find out more
LKIM

Lawson Kroeker Investment Management Portfolio holdings

AUM $361M
1-Year Est. Return 22.26%
This Fund
S&P 500
This Quarter Est. Return
+4.32%
1 Year Est. Return
+22.26%
3 Year Est. Return
+64.49%
5 Year Est. Return
+92.04%
10 Year Est. Return
+404.21%
AUM
$417M
AUM Growth
-$28.9M
Cap. Flow
-$38.8M
Cap. Flow %
-9.32%
Top 10 Hldgs %
38.03%
Holding
91
New
3
Increased
11
Reduced
48
Closed
12

Sector Composition

Rank Sector Weight
1 Financials 20.87%
2 Healthcare 16.82%
3 Industrials 14.96%
4 Energy 12.21%
5 Consumer Discretionary 12.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPL icon
1
Texas Pacific Land
TPL
$24.2B
$25.4M 6.09%
173,322
+1,782
+1% +$286K
BRK.B icon
2
Berkshire Hathaway Class B
BRK.B
$1.13T
$25.3M 6.08%
74,290
-982
-1% -$320K
MSFT icon
3
Microsoft
MSFT
$3.76T
$15.7M 3.76%
46,026
-585
-1% -$183K
AZO icon
4
AutoZone
AZO
$50.1B
$14.7M 3.53%
5,896
-16
-0.3% -$40.8K
CPRT icon
5
Copart
CPRT
$27.4B
$14.4M 3.47%
316,582
-574
-0.2% -$23.8K
LECO icon
6
Lincoln Electric
LECO
$15.1B
$13.6M 3.26%
68,281
-830
-1% -$145K
BRK.A icon
7
Berkshire Hathaway Class A
BRK.A
$1.13T
$12.9M 3.11%
25
ELV icon
8
Elevance Health
ELV
$86.2B
$12.2M 2.92%
27,396
+20,516
+298% +$9.46M
HSY icon
9
Hershey
HSY
$36.7B
$12.2M 2.92%
48,680
-850
-2% -$223K
GOOG icon
10
Alphabet (Google) Class C
GOOG
$4.35T
$12.1M 2.91%
100,040
-40
-0% -$4.63K
CRL icon
11
Charles River Laboratories
CRL
$13.2B
$11.6M 2.78%
55,162
+223
+0.4% +$44.4K
AFL icon
12
Aflac
AFL
$61.1B
$11.6M 2.77%
165,598
-210
-0.1% -$14.1K
PSX icon
13
Phillips 66
PSX
$86B
$10.5M 2.52%
110,228
+2,930
+3% +$285K
DIS icon
14
Walt Disney
DIS
$178B
$9.35M 2.24%
104,691
-1,960
-2% -$186K
FITB
15
Fifth Third Bancorp
FITB
$51.8B
$9.18M 2.2%
350,331
+4,733
+1% +$122K
BN icon
16
Brookfield
BN
$109B
$9.16M 2.2%
408,186
-22,880
-5% -$485K
PFE icon
17
Pfizer
PFE
$154B
$8.79M 2.11%
239,517
+1,725
+0.7% +$67.1K
TMO icon
18
Thermo Fisher Scientific
TMO
$222B
$8.64M 2.07%
16,551
-230
-1% -$124K
BOC icon
19
Boston Omaha
BOC
$429M
$8.6M 2.06%
456,717
-688
-0.2% -$14K
DVA icon
20
DaVita
DVA
$11.7B
$8.25M 1.98%
82,088
CP icon
21
Canadian Pacific Kansas City
CP
$79.6B
$8.14M 1.95%
100,748
-2,710
-3% -$214K
CIVI
22
DELISTED
Civitas Resources
CIVI
$7.48M 1.8%
+107,854
New +$7.46M
CVX icon
23
Chevron
CVX
$382B
$7.23M 1.74%
45,954
-36
-0.1% -$5.77K
GIL icon
24
Gildan
GIL
$10.6B
$7.05M 1.69%
218,787
+1,344
+0.6% +$41.2K
LKQ icon
25
LKQ Corp
LKQ
$6.22B
$6.99M 1.68%
119,974
-350
-0.3% -$19.5K

Similar funds

Lawson Kroeker Investment Management's Q2 2023 Portfolio in Review

As of Q2 2023, Lawson Kroeker Investment Management held 91 positions worth $417M, down 6.5% from $445M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Lawson Kroeker Investment Management withdrew a net $38.8M in Q2 2023, closing 12 positions and reducing 48 holdings. Its most notable exit was Arthur J. Gallagher & Co, an estimated $15.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Lawson Kroeker Investment Management opened a new position in Civitas Resources worth $7.48M.

  • Lawson Kroeker Investment Management's largest Q2 2023 buy was Civitas Resources: 107,854 shares worth $7.48M.
  • Lawson Kroeker Investment Management added most to Elevance Health in Q2 2023, an estimated $9.46M increase.
  • Lawson Kroeker Investment Management's biggest Q2 2023 reduction was Weyerhaeuser, cutting an estimated $4M.
  • Lawson Kroeker Investment Management fully exited Arthur J. Gallagher & Co in Q2 2023, selling an estimated $15.3M.
  • Lawson Kroeker Investment Management's ten largest holdings make up 38% of its $417M portfolio in Q2 2023.
  • Lawson Kroeker Investment Management opened 3 new positions and closed 12 in Q2 2023.
  • Lawson Kroeker Investment Management's portfolio value fell 6.5% quarter-over-quarter to $417M.

Based on Lawson Kroeker Investment Management's 13F filing for Q2 2023, filed 24 Jul 2023.